AG
OLMA icon

Algert Global’s Olema Pharmaceuticals OLMA Stock Holding History

Algert Global’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
80,928
+45,048
+126% +$603K 0.01% 970
2026
Q1 		$535K Buy
+35,880
New +$799K 0.01% 960
2024
Q2 		– Sell
-33,580
Closed -$380K – 1568
2024
Q1 		$380K Buy
+33,580
New +$433K 0.01% 837
2023
Q4 		– Sell
-47,630
Closed -$588K – 1222
2023
Q3 		$588K Sell
47,630
-10,460
-18% -$107K 0.03% 694
2023
Q2 		$525K Buy
58,090
+45,640
+367% +$276K 0.02% 808
2023
Q1 		$43.2K Sell
12,450
-9,790
-44% -$39.9K ﹤0.01% 1104
2022
Q4 		$54.5K Hold
22,240
– – ﹤0.01% 1101
2022
Q3 		$61K Buy
+22,240
New +$94.3K ﹤0.01% 1133

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Algert Global's OLMA Position: Q2 2026 in Review

Algert Global increased its Olema Pharmaceuticals (OLMA) stake by 126% in Q2 2026, buying an estimated $603K and bringing the position to 80,928 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #970.

Algert Global first reported a position in OLMA in Q3 2022 and has held it in 8 quarters since. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Algert Global held 80,928 shares of Olema Pharmaceuticals worth $1.01M as of Q2 2026.
  • Algert Global bought 45,048 Olema Pharmaceuticals shares in Q2 2026, an estimated $603K.
  • Olema Pharmaceuticals made up 0.01% of Algert Global's portfolio in Q2 2026, its #970 holding.
  • Algert Global first reported a position in Olema Pharmaceuticals in Q3 2022 and has held it in 8 quarters since.
  • 186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.